BioCardia, Inc. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
BioCardia, Inc. (BCDA) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of $217.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-12
- BioCardia, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was $20.00K.
- BioCardia, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was $197.00K, a 57.82% decline year-over-year.
- BioCardia, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was -$73.00K.
- BioCardia, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was -$194.00K.
- BioCardia, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was $179.00K.
- BioCardia, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was -$538.00K, a 211.62% decline from fiscal 2023.
- BioCardia, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was $482.00K, a 15.87% increase from fiscal 2022.
- BioCardia, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was $416.00K, a 220.00% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $217.00K 10-Q · filed 2026-08-12 | $144.00K derived: sum of 3 quarters · filed 2026-08-12 | -$50.00K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2026-03-31 | $197.00K 10-Q · filed 2026-05-15 | $124.00K derived: sum of 2 quarters · filed 2026-05-15 | -$70.00K derived: sum of 3 quarters · filed 2026-05-15 | -$91.00K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-12-31 | -$73.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$267.00K derived: sum of 2 quarters · filed 2026-03-24 | -$288.00K derived: sum of 3 quarters · filed 2026-08-12 | $179.00K 10-K · filed 2026-03-24 | |
| 2025-09-30 | -$194.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$215.00K derived: sum of 2 quarters · filed 2026-08-12 | $252.00K 10-Q · filed 2025-11-12 | $199.00K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-06-30 | -$21.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $446.00K 10-Q · filed 2026-08-12 | $393.00K derived: sum of 3 quarters · filed 2026-08-12 | $27.00K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-03-31 | $467.00K 10-Q · filed 2026-05-15 | $414.00K derived: sum of 2 quarters · filed 2026-05-15 | $48.00K derived: sum of 3 quarters · filed 2026-05-15 | -$382.00K derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | -$53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$419.00K derived: sum of 2 quarters · filed 2026-03-24 | -$849.00K derived: sum of 3 quarters · filed 2026-03-24 | -$538.00K 10-K · filed 2026-03-24 | -$678.00K 10-K · filed 2025-03-26 |
| 2024-09-30 | -$366.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2025-11-12 | -$796.00K derived: sum of 2 quarters · filed 2025-11-12 | -$485.00K 10-Q · filed 2025-11-12 | -$601.00K derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | -$430.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2025-10-29 | -$119.00K 10-Q/A · filed 2025-10-29 | -$235.00K derived: sum of 3 quarters · filed 2025-10-29 | $10.00K derived: sum of 4 quarters · filed 2025-10-29 | |
| 2024-03-31 | $311.00K 10-Q · filed 2025-05-14 | $195.00K derived: sum of 2 quarters · filed 2025-05-14 | $440.00K derived: sum of 3 quarters · filed 2025-05-14 | $567.00K derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | -$116.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $129.00K derived: sum of 2 quarters · filed 2025-03-26 | $256.00K derived: sum of 3 quarters · filed 2025-03-26 | $482.00K 10-K · filed 2025-03-26 | |
| 2023-09-30 | $245.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $372.00K derived: sum of 2 quarters · filed 2024-11-13 | $598.00K 10-Q · filed 2024-11-13 | $749.00K derived: sum of 4 quarters · filed 2024-11-13 | |
| 2023-06-30 | $127.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $353.00K 10-Q · filed 2024-08-13 | $504.00K derived: sum of 3 quarters · filed 2024-08-13 | $856.00K derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | $226.00K 10-Q · filed 2024-05-14 | $377.00K derived: sum of 2 quarters · filed 2024-05-14 | $729.00K derived: sum of 3 quarters · filed 2024-05-14 | $843.00K derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | $151.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $503.00K derived: sum of 2 quarters · filed 2024-03-27 | $617.00K derived: sum of 3 quarters · filed 2024-03-27 | $416.00K 10-K · filed 2024-03-27 | |
| 2022-09-30 | $352.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $466.00K derived: sum of 2 quarters · filed 2023-11-08 | $265.00K 10-Q · filed 2023-11-08 | $361.00K derived: sum of 4 quarters · filed 2023-11-08 | |
| 2022-06-30 | $114.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$87.00K 10-Q · filed 2023-08-09 | $9.00K derived: sum of 3 quarters · filed 2023-08-09 | $192.00K derived: sum of 4 quarters · filed 2023-08-09 | |
| 2022-03-31 | -$201.00K 10-Q · filed 2023-05-10 | -$105.00K derived: sum of 2 quarters · filed 2023-05-10 | $78.00K derived: sum of 3 quarters · filed 2023-05-10 | -$48.00K derived: sum of 4 quarters · filed 2023-05-10 | |
| 2021-12-31 | $96.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $279.00K derived: sum of 2 quarters · filed 2023-03-29 | $153.00K derived: sum of 3 quarters · filed 2023-03-29 | $130.00K 10-K · filed 2023-03-29 | |
| 2021-09-30 | $183.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $57.00K derived: sum of 2 quarters · filed 2022-11-09 | $34.00K 10-Q · filed 2022-11-09 | $116.00K derived: sum of 4 quarters · filed 2022-11-09 | |
| 2021-06-30 | -$126.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$149.00K 10-Q · filed 2022-08-10 | -$67.00K derived: sum of 3 quarters · filed 2022-08-10 | -$60.00K derived: sum of 4 quarters · filed 2022-08-10 | |
| 2021-03-31 | -$23.00K 10-Q · filed 2022-05-11 | $59.00K derived: sum of 2 quarters · filed 2022-05-11 | $66.00K derived: sum of 3 quarters · filed 2022-05-11 | $481.00K derived: sum of 4 quarters · filed 2022-05-11 | |
| 2020-12-31 | $82.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $89.00K derived: sum of 2 quarters · filed 2022-03-29 | $504.00K derived: sum of 3 quarters · filed 2022-03-29 | $797.00K 10-K · filed 2022-03-29 | |
| 2020-09-30 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $422.00K derived: sum of 2 quarters · filed 2021-11-10 | $715.00K 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $415.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $708.00K 10-Q · filed 2021-08-12 | |||
| 2020-03-31 | $293.00K 10-Q · filed 2021-05-13 | ||||
| 2019-09-30 | $215.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $723.00K derived: sum of 2 quarters · filed 2020-11-10 | $687.00K 10-Q · filed 2020-11-10 | ||
| 2019-06-30 | $508.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $472.00K 10-Q · filed 2019-08-14 | |||
| 2019-03-31 | -$36.00K 10-Q · filed 2019-05-15 | ||||
| 2018-09-30 | $116.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-19 | $107.00K derived: sum of 2 quarters · filed 2019-11-19 | $141.00K 10-Q · filed 2019-11-19 | ||
| 2018-06-30 | -$9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $25.00K 10-Q · filed 2019-08-14 | |||
| 2018-03-31 | $34.00K 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |